Literature DB >> 28223179

Biological aspects of axonal damage in glaucoma: A brief review.

Ernst R Tamm1, C Ross Ethier2.   

Abstract

Intraocular pressure (IOP) is a critical risk factor in glaucoma, and the available evidence derived from experimental studies in primates and rodents strongly indicates that the site of IOP-induced axonal damage in glaucoma is at the optic nerve head (ONH). However, the mechanisms that cause IOP-induced damage at the ONH are far from understood. A possible sequence of events could originate with IOP-induced stress in the ONH connective tissue elements (peripapillary sclera, scleral canal and lamina cribrosa) that leads to an increase in biomechanical strain. In consequence, molecular signaling cascades might be activated that result in extracellular matrix turnover of the peripapillary sclera, changing its biomechanical properties. Peripapillary sclera strain might induce reactive changes in ONH astrocytes and cause astrogliosis. The biological changes that are associated with ONH astrocyte reactivity could lead to withdrawal of trophic or metabolic support for optic nerve axons and cause their degeneration. Alternatively, the expression of neurotoxic molecules might be induced. Unfortunately, direct experimental in vivo evidence for these or other scenarios is currently lacking. The pathogenic processes that cause axonal degeneration at the ONH in glaucoma need to be identified before any regenerative therapy is likely to succeed. Several topics and emerging techniques should be pursued to enhance our understanding of the mechanisms that are behind axonal degeneration. Among them are: Advanced imaging techniques, the development of in vivo markers to identify axonal injury, the generation of molecular approaches for in vivo detection of mechanosensitivity and for molecular manipulation of the ONH, a more complete characterization of retinal ganglion cells, the use of organ cultures, 3D-bioprinting, and the engineering of microdevices that can measure pressure. Questions that need to be answered relate to the specific roles of astrogliosis, neuroinflammation, blood flow and intracranial pressure in axonal degeneration at the ONH.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28223179      PMCID: PMC6545378          DOI: 10.1016/j.exer.2017.02.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  81 in total

1.  Chronology of optic nerve head and retinal responses to elevated intraocular pressure.

Authors:  E C Johnson; L M Deppmeier; S K Wentzien; I Hsu; J C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

2.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

3.  Transforming growth factor beta isoforms in human optic nerve heads.

Authors:  J D Pena; A W Taylor; C S Ricard; I Vidal; M R Hernandez
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

4.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

5.  Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.

Authors:  D S Lim; S Lutucuta; P Bachireddy; K Youker; A Evans; M Entman; R Roberts; A J Marian
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

6.  Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage.

Authors:  Balwantray C Chauhan; Jingyi Pan; Michele L Archibald; Terry L LeVatte; Melanie E M Kelly; François Tremblay
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

7.  Very Slow Retrograde and Wallerian Degeneration in the CNS of C57BL/Ola Mice.

Authors:  V H Perry; M C Brown; E R Lunn
Journal:  Eur J Neurosci       Date:  1991       Impact factor: 3.386

8.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

9.  Morphology of the murine optic nerve.

Authors:  Chr Albrecht May; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

10.  Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Authors:  M Cristina Leske; Anders Heijl; Mohamed Hussein; Bo Bengtsson; Leslie Hyman; Eugene Komaroff
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  26 in total

Review 1.  Biomechanical aspects of axonal damage in glaucoma: A brief review.

Authors:  Cheri Stowell; Claude F Burgoyne; Ernst R Tamm; C Ross Ethier
Journal:  Exp Eye Res       Date:  2017-02-20       Impact factor: 3.467

2.  Characterizing the Collagen Network Structure and Pressure-Induced Strains of the Human Lamina Cribrosa.

Authors:  Yik Tung Tracy Ling; Ran Shi; Dan E Midgett; Joan L Jefferys; Harry A Quigley; Thao D Nguyen
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-06-03       Impact factor: 4.799

3.  The effects of intravitreal H2 S application on apoptosis in the retina and cornea in experimental glaucoma model.

Authors:  Zuleyha Erisgin; Murat Atabey Ozer; Murat Tosun; Serkan Ozen; Selcuk Takir
Journal:  Int J Exp Pathol       Date:  2019-11-27       Impact factor: 1.925

4.  The primate model for understanding and restoring vision.

Authors:  Serge Picaud; Deniz Dalkara; Katia Marazova; Olivier Goureau; Botond Roska; José-Alain Sahel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

5.  Racioethnic differences in the biomechanical response of the lamina cribrosa.

Authors:  Reza Behkam; Hirut G Kollech; Anirban Jana; Amy Hill; Forest Danford; Stephen Howerton; Sundaresh Ram; Jeffrey J Rodríguez; Urs Utzinger; Christopher A Girkin; Jonathan P Vande Geest
Journal:  Acta Biomater       Date:  2019-02-20       Impact factor: 8.947

6.  Interplay between intraocular and intracranial pressure effects on the optic nerve head in vivo.

Authors:  Ziyi Zhu; Susannah Waxman; Bo Wang; Jacob Wallace; Samantha E Schmitt; Elizabeth Tyler-Kabara; Hiroshi Ishikawa; Joel S Schuman; Matthew A Smith; Gadi Wollstein; Ian A Sigal
Journal:  Exp Eye Res       Date:  2021-11-01       Impact factor: 3.467

Review 7.  Evidence for Menopause as a Sex-Specific Risk Factor for Glaucoma.

Authors:  Amber Douglass; Michael Dattilo; Andrew J Feola
Journal:  Cell Mol Neurobiol       Date:  2022-01-04       Impact factor: 4.231

8.  ZO-1 associates with α3 integrin and connexin43 in trabecular meshwork and Schlemm's canal cells.

Authors:  Xinbo Li; Ted S Acott; James I Nagy; Mary J Kelley
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-02-25

9.  Microtubule Imaging Reveals Cytoskeletal Deficit Predisposing the Retinal Ganglion Cell Axons to Atrophy in DBA/2J.

Authors:  Denis Sharoukhov; Festa Bucinca-Cupallari; Hyungsik Lim
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-11-01       Impact factor: 4.799

10.  CCN2/CTGF promotor activity in the developing and adult mouse eye.

Authors:  Andrea E Dillinger; Sabrina Kuespert; Franziska Froemel; Ernst R Tamm; Rudolf Fuchshofer
Journal:  Cell Tissue Res       Date:  2021-01-29       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.